Advances in Treatment of Bipolar Disorders provides clinicians with a well-written and timely guide to the most recent advances in the treatment of patients with this complex disorder. Staying abreast of new research developments and treatment options presents a daunting challenge, but the editor and coauthors have compiled the most important evidence-based findings from controlled studies and U.S. Food and Drug Administration approved indications, facilitating integration of these findings into clinical practice. This volume strives to provide clinicians with the necessary information to enable them to balance the likelihood of benefit (using “number needed to treat” analyses) versus harm (using “number needed to harm” analyses) in order to provide individualized, state-of-the-art, evidence-based care. The most current research findings are complemented by the authors’ extensive personal clinical experiences, resulting in a volume that reflects the most up-to-date thinking about the diagnosis and management of bipolar disorder. Advances in Treatment of Bipolar Disorders belongs in every mental health clinician’s library.

Despite works published as recently as 2002, the continuing rapid evolution of new medications and adjunctive psychosocial interventions for bipolar disorder has made the concise Advances in Treatment of Bipolar Disorder essential for today's clinicians who want to stay abreast of the latest developments in treating this complex and challenging mental illness. Meticulously referenced with numerous tables and illustrations, Advances in Treatment of Bipolar Disorder offers a very timely and exciting perspective on new ways to treat bipolar disorder. After an overview, six succinct chapters written by experts review recent developments -- emphasizing interventions supported by controlled studies -- in the following areas: Advances in treatment of patients with acute mania: discussing newer antipsychotics, which as a class are effective as primary treatments for acute mania, and have emerging potential roles in maintenance treatment, and acute bipolar depression; and anticonvulsants, some of which are effective for as primary treatments for acute mania or maintenance, and others of which although not primary treatments for bipolar disorders may provide benefits as adjuncts for comorbid conditions. New developments in the treatment of acute bipolar depression: describing therapeutic options beyond mood stabilizers and highlighting that adjunctive use of antidepressants requires additional adequately powered controlled studies to support this common approach. Techniques in the maintenance treatment of patients with bipolar disorder: including both medications and adjunctive psychosocial therapies, which together can help clinicians manage medication adverse effects and maintain the therapeutic alliance, treatment adherence, and involvement of significant others to enhance outcomes. Innovations in the treatment of rapid-cycling bipolar disorder: although no treatment has received FDA approval for the management of this challenging presentation, results of controlled trials are beginning to provide clinically relevant insights in to the treatment of patients with rapid cycling, offering hope for more effective future therapies. The treatment of children and adolescents with bipolar disorder: no treatment has FDA approval for the treatment of pediatric patients with bipolar disorder and controlled data are limited, yet recent research is beginning to yield important new information about the diagnosis and management of children and adolescents with this illness or its putative prodromes. Phenomenology and management of bipolar disorder in women: introducing important new information to enhance clinicians' understanding of the importance of accounting for gender differences and reproductive health in the treatment of women with bipolar disorder. Advances in Treatment of Bipolar Disorder helps clinicians to better understand the utility of both older medications and important new treatment options as it highlights the need for additional research to ensure further progress in overcoming the challenges of caring for patients with bipolar disorder.

Clinicians searching for evidence-based quantitative assessments on which to base diagnosis and treatment of patients with bipolar disorder need look no further. Advances in Treatment of Bipolar Disorders analyzes the benefits and harms for both older and more recently developed treatments, and places these analyses in the context of the authors' many years of clinical experience. The result is a book that is both quantitatively sound and qualitatively rich, and one that will help clinicians understand the latest research and integrate it into their practices with confidence. In addition to comprehensive coverage of the most important recent advances, the book addresses advances in more specific areas, including the treatment of particular populations such as women, children, and older adults. In addition, the book covers many critically important topics and boasts an abundance of helpful features: Evidence-based quantitative assessments of benefits use "numbers needed to treat" for therapeutic effects and "numbers needed to harm" for side effects, ensuring that the quality of data supporting interventions meets a rigorous standard. The book's information is based not only on controlled trials and FDA approvals but also on almost two decades of clinical research and clinical treatment experience by clinicians at Stanford University. Plentiful figures and summary tables are provided to summarize the content and make it easy-to-grasp and clinician-friendly. In addition to coverage of acute bipolar depression and acute manic and mixed episodes, the book provides chapters on the preventive treatment of bipolar disorder and the pharmacology of mood-stabilizing and second-generation antipsychotic medications. Bipolar disorders are challenging and complex mental illnesses, and clinicians need all the help they can get in managing the effects of these illness on their patients' lives. Advances in Treatment of Bipolar Disorders aims to provide everything clinicians need to know to update their knowledge of this rapidly evolving field and ensure an evidence-based standard of care for this patient population.

This readable guide to the assessment and management of patients with bipolar disorder can help physicians keep abreast of dramatic and rapid advances of recent years and integrate them into their practice. Handbook of Diagnosis and Treatment of Bipolar Disorders emphasizes recent controlled studies and FDA-approved indications and translates these data into the real world of clinical practice. The contributions of the eleven chapter authors from Stanford University reflect more than a decade of clinical research and treatment undertaken at that institution, including advances in diagnosis and interventions supported by controlled studies. They provide crucial information regarding diagnosis, pharmacotherapy, psychotherapy, and treatment of patients from special populations -- such as children, women, and older adults -- and patients with particular challenging illness course such as rapid cycling. This is the first book to provide quantitative assessment of potential benefit (number needed to treat) and risk (number needed to harm) for all approved treatments for bipolar disorder, providing clinicians with information needed to balance benefits and risks in order to render individualized state-of-the-art, evidence-based care. It describes all FDA-approved indications -- reviewing efficacy, safety, tolerability, pharmacokinetics, illness phase-specific dosing, and drug interactions. A chapter on multiphase treatment strategy explains crucial illness transition points and describes how these have been integrated with knowledge of illness phase in mood disorders. The book then demonstrates the relevance of this approach to therapeutics by providing: An overview of pharmacotherapy that covers the emergence of evidence-based pharmacotherapy and number-needed-to-treat and -harm analyses. Guidelines to managing acute manic and mixed episodes that include evidence-based assessments of lithium, divalproex, carbamazepine, and second-generation antipsychotics. Coverage of acute major depressive episodes in bipolar disorders that outlines four tiers of treatment for this most pervasive illness phase with the fewest approved treatments. Discussion of the longer-term management of bipolar disorders, including reviews of controlled trials of recently approved pharmacotherapies such as lamotrigine, olanzapine, aripiprazole, and adjunctive quetiapine. A review of the use of mood stabilizers and second-generation antipsychotics, often in combinations, as well as the controversial role of adjunctive antidepressants in treating patients with rapid-cycling bipolar disorders. Description of important advances in evidence-based adjunctive psychotherapeutic interventions in bipolar depression, and bipolar maintenance treatment. Comprehensive in scope, yet readily accessible for application to clinical practice, the book includes summary tables, quick-reference lists of clinical pearls, and case studies to make its content more relevant. Handbook of Diagnosis and Treatment of Bipolar Disorders is the ideal source for integrating recent research into everyday practice.

A guide to treating psychosis that provides information on drug options and side-effects in order to allow for weighing treatment options knowledgably The Maudsley Guidelines on Advanced Prescribing in Psychosis offers a resource that puts the focus on the need to treat the individual needs of a patient. The authors – noted experts on the topic – offer an alternative to the one-size-fits-all treatment of psychosis and shows how to build psychiatrist and patient relationships that will lead to effective individual treatment plans. The book provides up-to-date data and information about commonly used anti-psychotic drugs and drugs used in bipolar disorder. The text weighs both the upsides and downsides of each pharmaceutical presented, and helps prescribers and patients weigh the costs and benefits of various options to reach an appropriate treatment plan. The authors highlight the treatment at a population level and the systems in which individual treatments take places. This important resource: Facilitates the tailoring of an appropriate treatment plan for clients manifesting signs of psychosis Offers a comparative strategy that helps gauge the suitability of one treatment plan over another Provides at-hand data and information about commonly used anti-psychotic drugs Includes an understanding of the origins and side-effects of each drug presented The Maudsley Guidelines on Advanced Prescribing in Psychosis offers psychiatrists and other mental health practitioners an essential guide for treating psychosis on an individualized level.

An essential update of recent clinical trials in the management of neurological and neuropsychiatric disorders.

Now updated to keep professionals current with the latest research and trends in the field, this edition covers both basic science and clinical practice, and draws on the talents of 53 new contributors to guarantee fresh, authoritative perspectives on advances in psychiatric drug therapy.

Named a 2013 Doody's Core Title! "There are few new books to direct PMH-APRN treatment options...Now, this book provides the path to integration of treatment options for the holistic care of psychiatric client by PMH-APRNs."--Doody's Medical Reviews ìThis text is a wonderful compilation of information that is needed within current advanced practice psychiatric mental health nursing. The chapters are informative, have excellent references and provide up to the minute information that is grounded in evidence-based practices.î Barbara Jones Warren, PhD, RN, CNS-BC, PMH, FAAN Professor, Clinical Nursing Director, Psychiatric Nursing Specialty National Institutes of Health/American Nurses Association Ethnic/Racial Minority Fellow The Ohio State College of Nursing This groundbreaking core text fills a void in nursing literature by integrating psychotherapy, psychopharmacology, and complementary and alternative medicine (CAM) approaches into advanced practice nursing. It is organized around psychiatric "syndromes" rather than DSM diagnoses, so it will remain current even after the publication of the DSM-5. The book provides clear and relevant treatment options in the form of decision trees with additional explanatory narratives. These decision trees enable practitioners to distinguish ìnormalî patients from those who require more customized therapeutic interventions. This holistic text integrates neurobiology, theory, and research evidence related to psychotherapy, psychopharmacology, and complementary and alternative medicine interventions. While providing comprehensive information on theory and practice, it simplifies complex aspects of treatment with clarity and provides the depth of content appropriate to support sound clinical reasoning required in advanced practice. The book responds to the current backlash against overmedication in psychiatry. It also fulfills the upcoming requirements by APNA and ISPN that advanced practice psychiatric nurses must have skills in psychotherapy. Additionally, the text focuses on treatment issues across the life span and highlights pertinent clinical differences from the adult population through pediatric pointers and aging alerts. Advanced Practice Psychiatric Nursing reflects the extensive practice and educational experience of editors and contributors from the United States, Canada, and Scotland, all of whom are expert APNs. Key Features: Organized around psychiatric ìsyndromes,î rather than DSM diagnoses, so it will remain relevant after the DSM-5 is published Integrates neurobiology, theory, and research evidence related to psychotherapy. psychopharmacology, and CAM therapies Provides the much-needed content on psychotherapy newly required for all psychiatric advanced practice nurses (APNA & ISPN White Papers) Supports clinical decision skills through thoughtfully designed, easy-to-follow decision trees ICONS highlight life span clinical management differences through Pediatric Pointers and Aging Alerts

In the realm of healthcare and holistic healing, there exists an intricate tapestry of methodologies, each contributing its unique thread to the fabric of wellness. It is within this intricate weave that we embark on a journey to explore a groundbreaking approach in the treatment of a complex condition: Polycystic Kidney Disease (PKD). This book, "Advanced Treatment for Polycystic Kidney Disease: Apometry, NLP, Regression and Hypnosis," is the culmination of extensive research, innovative thinking, and a deep commitment to improving the lives of those affected by PKD. Polycystic Kidney Disease, a condition that affects countless individuals worldwide, calls for a multi-faceted approach that goes beyond conventional medical practices. Through diligent study and experimentation, we have endeavored to present a holistic framework that incorporates Apometry, Neuro-Linguistic Programming (NLP), Regression, and Hypnosis – each contributing its unique strengths to the journey of healing. In the pages that follow, we will delve into the intricacies of these methodologies, exploring how Apometry's unique energy-based approach can complement the power of NLP's cognitive restructuring. We'll venture into the realm of Regression, unearthing the potential of revisiting past experiences for insight and healing, while also embracing Hypnosis's ability to tap into the subconscious mind's innate capacity for transformation. The scope of this book extends beyond the immediate treatment of PKD. It encompasses a spectrum of subjects – from the ethereal realms of consciousness and parapsychology to the practical applications of genetic insights and therapeutic techniques. While our focus remains steadfast on PKD, we recognize that the insights and methodologies presented here have broader implications for holistic health and wellness. As you embark on this exploration, we encourage you to approach each chapter with an open mind and a curious heart. Our intention is not to provide a definitive solution, but rather to open a dialogue and stimulate new ways of thinking about healthcare, healing, and the intricate interplay between body, mind, and spirit. We extend our heartfelt gratitude to the individuals, practitioners, and researchers who have contributed to the development of the ideas presented in this book. Your dedication to advancing our understanding of holistic healing is truly commendable. May this book serve as a guide, an inspiration, and a catalyst for transformative conversations within the realms of healthcare, consciousness, and holistic well-being.

Meet the diverse health care needs of older adults! Explore effective ways to enhance the wellness and independence of older adults across the wellness-illness continuum, including acute, primary, and long-term care. From an overview of the theories of aging and assessment through the treatment of disorders, including complex illnesses, this evidence-based book provides the comprehensive gerontological coverage you need to prepare for your role as an Advanced Practice Nurse. You’ll be prepared for boards and for practice.